Manufacturers Life Insurance Company, The Keros Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 16,806 shares of KROS stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,806
Previous 16,833
0.16%
Holding current value
$1.01 Million
Previous $769,000
26.79%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding KROS
# of Institutions
174Shares Held
30.3MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$152 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$115 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$112 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.52MShares$92 Million7.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$91.4 Million0.01% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.55B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...